Digest Network Come funziona
Network
/
Società
Pu
Non verificato

Purdue Pharma L.P.

Di cosa scriviamo

FarmaceuticaIgiene alimentareIndustriaMedicina - VarieSalute

12 comunicati stampa

Guarda tutti i comunicati
19/11/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Industria
Tinostamustine Shows Early Signals of Activity in Phase 1 Glioblastoma Trial
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
14/11/2025
Finanza
Legge/Diritto
Salute
Farmaceutica
Bankruptcy Court to Confirm Purdue Pharma’s Plan of Reorganization
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
10/11/2025
Industria
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
FDA Grants Orphan Drug Designation for Tinostamustine in Malignant Glioma
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
21/10/2025
Salute
Farmaceutica
Legge/Diritto
Finanza
Purdue Pharma L.P. Plan of Reorganization Receives Overwhelming Creditor Support
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
29/09/2025
Analisi di mercato
Industria
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
New Study Examines Nalmefene Auto-Injector and Intranasal Naloxone for Reversal of Respiratory Depression Induced by Fentanyl in a Controlled Clinical Study
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
17/09/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Industria
Investigational Drug Tinostamustine to be Included in GBM AGILE Clinical Trial for Glioblastoma
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
02/09/2025
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Purdue Pharma L.P. Expands its Provision of Low-Cost Opioid Use Disorder Treatment to Correctional Facilities for Incarcerated Individuals
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
20/06/2025
Salute
Farmaceutica
Legge/Diritto
Finanza
Purdue Pharma L.P. Receives Court Approval of Disclosure Statement Filed in Connection with its Plan of Reorganization
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
19/03/2025
Finanza
Sanità
Igiene alimentare
Salute
Farmaceutica
Attrezzature medico-sanitarie
Purdue Pharma L.P. Files New Plan of Reorganization Providing for More Than $7.4 Billion in Creditor Distributions
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0
28/10/2024
Industria
Attrezzature medico-sanitarie
Igiene alimentare
Medicina - Varie
Cardiologia
Biotecnologia
Sanità
Salute
Farmaceutica
New Study Explores Nalmefene and Naloxone for Reversal of Respiratory Depression Induced by Fentanyl in a Clinical Opioid Induced Respiratory Depression Model
Fonte
Purdue Pharma L.P.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0